Haemophilus Influenzae Type b Conjugate Vaccine (Tianjin Cansino Biotechnology)

b型流感嗜血杆菌结合疫苗（康希诺生物）

Report date: 2024/07/08 14:15:38

Base Information

Drug NameHaemophilus Influenzae Type b Conjugate Vaccine (Tianjin Cansino Biotechnology)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccineVaccines > Development/production technology > Conjugated vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHaemophilus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesTianjin Cansino Biotechnology Inc

China Registration ClassN/A

Develop Information

Active CompaniesTianjin Cansino Biotechnology Inc

Inactive CompaniesN/A

Active IndicationsHaemophilus Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A